- Location
Zhejiang Hisun
"-
The CFDA Has Approved Ginsenoside CK to Enter Clinical Test Phase
Sep 11, 2013Reporters learnt from the China Food and Drug Administration (CFDA) that the government agency has approved Ginsenoside CK of Zhejiang Hisun Pharmaceutical Co., Ltd. (SHSE: 600267) to enter clinical test phase. Ginsenoside CK has ...
-
Controlling Shareholder Zhejiang Hisun Planned to Offer Medium Term Notes
May 24, 2013Zhejiang Hisun Pharmaceutical Co., Ltd. (SHSE: 600267) revealed that controlling shareholder Zhejiang Hisun Group Co., Ltd. planned to offer medium term notes worth CNY 400 million to the company and related affiliates for replenishing ...
Tags: Zhejiang Hisun, Subsidies
-
Pfizer and Zhejiang Hisun Have Launched a Joint Venture,Hisun-Pfizer Pharmaceuticals
Nov 29, 2012Pfizer, a research-based pharmaceutical company, and Zhejiang Hisun Pharmaceuticals, a Chinese pharmaceutical company, have launched a joint venture, Hisun-Pfizer Pharmaceuticals. Hisun-Pfizer is expected to develop, manufacture and ...